Financhill
Sell
46

RVTY Quote, Financials, Valuation and Earnings

Last price:
$111.02
Seasonality move :
5.29%
Day range:
$110.15 - $113.66
52-week range:
$97.32 - $129.50
Dividend yield:
0.25%
P/E ratio:
54.47x
P/S ratio:
5.10x
P/B ratio:
1.73x
Volume:
1.9M
Avg. volume:
992.7K
1-year change:
8.18%
Market cap:
$13.7B
Revenue:
$2.8B
EPS (TTM):
$2.07

RVTY Analysts' Consensus Rating

The 15 analysts providing 12-month price projections for Revvity shares anticipate an average target of $138.47, ranging from a low estimate of $120.00 to a high estimate of $163.44. This average target implies a growth of 23.02% compared to the current stock price of $112.56.

Consensus Price Target

$138.47

Highest Price Target

$163.44

Lowest Price Target

$120.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 8 8 9

Hold 7 7 6

Sell 0 0 0
Consensus Buy Buy Buy

RVTY Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.46% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 14.53% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.83% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock